Closing Remarks


Sentinel Node Sentinel Lymph Node Biopsy Axillary Lymph Node Dissection Sentinel Lymph Node Dissection Interval Node 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Badgwell BD, Povoski SP, Abdessalam SF, Young DC, Farrar WB, Walker MJ, Yee LD, Zervos EE, Carson WE 3rd, Burak WE Jr (2003) Patterns of recurrence after sentinel lymph node biopsy for breast cancer. Ann Surg Oncol 10(4):376–380CrossRefPubMedGoogle Scholar
  2. Blumenfhal R, Banic A, Brand CU, Ris HB, Lardinois D (2002) Morbidity and outcome after sentinel lymph node dissection in patients with early-stage malignant cutaneous melanoma. Swiss Surg 8(5):209–214PubMedGoogle Scholar
  3. Burak WE, Hollenbeck ST, Brand CU, Ris HB, Lardinois D (2002) Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 183(1):23–27CrossRefPubMedGoogle Scholar
  4. Cascinelli N, Belli F, Santinami M, Fait V, Testori A, Ruka W, Cavaliere R, Mozzillo N, Rossi CR, MacKie RM, Nieweg O, Pace M, Kirov K (2000) Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 7(6):469–474CrossRefPubMedGoogle Scholar
  5. Haid A, Köberle-Wührer R, Knauer M, Burtscher J, Fritzsche H, Peschina W, Jasarevic Z, Ammann M, Hergan K, Sturn H, Zimmermann G (2002) Morbidity of breast cancer patients following complete axilla dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 73(1):31–36CrossRefPubMedGoogle Scholar
  6. Hansen NM, Grube BJ, Giuliano AE (2002) The time has come to change the algorithm for the surgical management of early breast cancer. Arch Surg 137(10):1131–1135CrossRefPubMedGoogle Scholar
  7. Hunt JA, Thompson JF, Uren RF, Howman-Giles R, Harman CR (1998) Epitrochlear lymph-nodes as a site of melanoma metastasis. Ann Surg Oncol 5(3):248–252PubMedGoogle Scholar
  8. Meijer S, Torrenga H, van der Sijp JR (2002) Negative sentinel node in breast cancer patients a good indicator for continued absence of axillary metastases. Ned Tijdschr Geneeskd 146(20):942–946PubMedGoogle Scholar
  9. Morton DL, Thompson JF, Essner R, Elashoff R, Stern SL, Nieweg OE, Roses DF, Karakousis CP, Mozzillo N, Reintgen D, Wang HJ, Glass EC, Cochran AJ (1999) Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 230(4):453–463CrossRefPubMedGoogle Scholar
  10. Nieweg OE, Tanis PJ, Rütgers EJT (2000) Summary of the Second International Sentinel Node Conference. Eur J Nucl Med 28:646Google Scholar
  11. Shivers S, Cox C, Leight G, Beauchamp D, Blumencranz P, Ross M, Reintgen D (2002) Final results of the Department of Defence Multicenter Breast Lymphatic Mapping Trial. Ann Surg Oncol 9(3):248–255CrossRefPubMedGoogle Scholar
  12. Thompson JF, Saw RP, Colman MH, Howman-Giles RB, Uren RF (1997) Contralateral groin node metastasis from lower limb melanoma. Eur J Cancer 33(6):976–977CrossRefPubMedGoogle Scholar
  13. Thompson JF, Uren RF, Shaw HM, McCarthy WH, Quinn MJ, O'Brien CJ, Howman-Giles RB (1999) Location of sentinel lymph-nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg 189(2):195–204CrossRefPubMedGoogle Scholar
  14. Thompson JF, Hunt JA, Culjak G, Uren RF, Howman-Giles R, Harman CR (2000) Popliteal lymph node metastasis from primary cutaneous melanoma. Eur J Surg Oncol 26(2):172–176CrossRefPubMedGoogle Scholar
  15. Uren RF, Howman-Giles RB, Thompson JF (1998) Failure to detect drainage to the popliteal and epitrochlear lymph-nodes on cutaneous lymphoscintigraphy in melanoma patients. J Nucl Med 39(12):2195Google Scholar
  16. Uren RF, Howman-Giles R, Thompson JF (1999 a) Direct lymphatic drainage from a melanoma on the back to paravertebral lymph-nodes in the thorax. Clin Nucl Med 24(6):388–389CrossRefPubMedGoogle Scholar
  17. Uren RF, Thompson JF, Howman-Giles R, Shaw HM (1999 b) Melanoma metastases in triangular intermuscular space lymph-nodes. Ann Surg Oncol 6(8):811CrossRefPubMedGoogle Scholar
  18. Uren RF, Howman-Giles R, Thompson JF, McCarthy WH, Quinn MJ, Roberts JM, Shaw HM (2000 a) Interval nodes: the forgotten sentinel nodes in patients with melanoma. Arch Surg 135(10):1168–1172CrossRefPubMedGoogle Scholar
  19. Uren RF, Thompson JF, Howman-Giles R (2000 b) Sentinel nodes. Interval nodes, lymphatic lakes, and accurate sentinel node identification. Clin Nucl Med 25(3):234–236CrossRefPubMedGoogle Scholar
  20. Vuylsteke RJ, van Leeuwen PA, Müller MG, Gietma HA, Kragt DR, Meijer S (2003) Clinical outcome of stage I/II melanoma patients after selective lymph node dissection: long-term follow-up results. J Clin Oncol 21(6):1057–1065CrossRefPubMedGoogle Scholar
  21. Wallace VDR, Hoh CK, Mattrey RF (2001) A synthetic macromolecule for sentinel node detection: 99mTc-DTPA-mannosyl dextran. J Nucl Med 42:951–959PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Personalised recommendations